JP2008508188A5 - - Google Patents

Download PDF

Info

Publication number
JP2008508188A5
JP2008508188A5 JP2007504792A JP2007504792A JP2008508188A5 JP 2008508188 A5 JP2008508188 A5 JP 2008508188A5 JP 2007504792 A JP2007504792 A JP 2007504792A JP 2007504792 A JP2007504792 A JP 2007504792A JP 2008508188 A5 JP2008508188 A5 JP 2008508188A5
Authority
JP
Japan
Prior art keywords
thiazol
ethyl
phenyl
amino
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007504792A
Other languages
English (en)
Japanese (ja)
Other versions
JP4978464B2 (ja
JP2008508188A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2005/014136 external-priority patent/WO2006011631A2/en
Publication of JP2008508188A publication Critical patent/JP2008508188A/ja
Publication of JP2008508188A5 publication Critical patent/JP2008508188A5/ja
Application granted granted Critical
Publication of JP4978464B2 publication Critical patent/JP4978464B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007504792A 2004-07-27 2005-07-27 Vap−1阻害剤活性を有するチアゾール誘導体 Expired - Fee Related JP4978464B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2004904196A AU2004904196A0 (en) 2004-07-27 Thiazole Derivatives Having VAP-1 Inhibitory Activity
AU2004904196 2004-07-27
PCT/JP2005/014136 WO2006011631A2 (en) 2004-07-27 2005-07-27 Thiazole derivatives having vap-1 inhibitory activity

Publications (3)

Publication Number Publication Date
JP2008508188A JP2008508188A (ja) 2008-03-21
JP2008508188A5 true JP2008508188A5 (enExample) 2008-08-14
JP4978464B2 JP4978464B2 (ja) 2012-07-18

Family

ID=35734947

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007504792A Expired - Fee Related JP4978464B2 (ja) 2004-07-27 2005-07-27 Vap−1阻害剤活性を有するチアゾール誘導体

Country Status (10)

Country Link
US (1) US20070254931A1 (enExample)
EP (1) EP1786792B1 (enExample)
JP (1) JP4978464B2 (enExample)
KR (1) KR20070050932A (enExample)
CN (1) CN101031555A (enExample)
AT (1) ATE427941T1 (enExample)
CA (1) CA2575411A1 (enExample)
DE (1) DE602005013793D1 (enExample)
ES (1) ES2324922T3 (enExample)
WO (1) WO2006011631A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8748627B2 (en) 2006-02-15 2014-06-10 Abbvie Inc. Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
US8735595B2 (en) * 2006-02-15 2014-05-27 Abbvie Inc. Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
US20100190834A1 (en) * 2007-06-25 2010-07-29 R-Tech Ueno, Ltd. Composition for ophtalmic disease associated with hypoxia or ischemia
CN101903045B (zh) 2007-10-19 2013-03-13 株式会社·R-技术上野 用于治疗白内障的药物组合物
WO2009061830A1 (en) * 2007-11-06 2009-05-14 Massachusetts Eye & Ear Infirmary Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap-1) inhibitor
ES2442298T3 (es) * 2008-01-18 2014-02-11 Allergan, Inc. Agentes alfa 2 adrenérgicos selectivos de subtipo y métodos para usarlos
TWI437986B (zh) 2008-01-31 2014-05-21 R Tech Ueno Ltd 噻唑衍生物及使用該衍生物作為vap-1抑制劑之用途
TWI490214B (zh) * 2008-05-30 2015-07-01 艾德克 上野股份有限公司 苯或噻吩衍生物及該等作為vap-1抑制劑之用途
EA022417B1 (ru) * 2008-10-21 2015-12-30 Саймабэй Терапевтикс, Инк. Арильные агонисты рецептора gpr120 и их применение
UA112154C2 (uk) 2009-09-08 2016-08-10 Біоті Терапіс Корп. Застосування повністю людського анти-vap-1-антитіла для лікування фіброзних станів
FI20115234A0 (fi) 2011-03-08 2011-03-08 Biotie Therapies Corp Uusia pyridatsinoni- ja pyridoniyhdisteitä
KR101879011B1 (ko) * 2011-03-15 2018-07-16 아스테라스 세이야쿠 가부시키가이샤 구아니딘 화합물
US8921576B2 (en) 2011-10-19 2014-12-30 Kowa Company, Ltd. Spiroindoline compound, and medicinal agent comprising same
CA2915163A1 (en) 2013-06-12 2014-12-18 Proximagen Limited New therapeutic uses of enzyme inhibitors
HUE042625T2 (hu) 2014-04-15 2019-07-29 Pecsi Tudomanyegyetem Szemikarbazid-szenzitiv amin-oxidáz gátlók fájdalomcsillapítóként való alkalmazásra traumás neuropátiában és neurogén gyulladásban
WO2015189534A1 (en) 2014-06-12 2015-12-17 Proximagen Limited Vap-1 inhibitors for treating muscular dystrophy
CN104478828B (zh) * 2014-12-10 2016-07-06 漳州片仔癀药业股份有限公司 2-氨基-7-取代苯并噻唑类化合物及其制备方法与用途
JO3546B1 (ar) 2015-01-09 2020-07-05 Kyowa Kirin Co Ltd طريقة لإنتاج مشتق ثيازول
JP2018076236A (ja) 2015-06-05 2018-05-17 株式会社アールテック・ウエノ がんを処置するための医薬組成物
EP3333163A4 (en) * 2015-08-06 2019-01-09 UBE Industries, Ltd. SUBSTITUTED GUANIDINE DERIVATIVE
US20180360808A1 (en) 2015-12-07 2018-12-20 Benevolentai Cambridge Limited Vap-1 inhibitors for treating pain
SI3455216T1 (sl) * 2016-05-12 2021-02-26 Boehringer Ingelheim International Gmbh Piridinilni derivati, farmacevtski sestavki in njihove uporabe kot AOC3 inhibitorji
HUE058181T2 (hu) * 2016-12-28 2022-07-28 Ube Industries Subsztituált guanidin vegyület
US10213306B2 (en) 2017-03-31 2019-02-26 Neochord, Inc. Minimally invasive heart valve repair in a beating heart
CN119661621A (zh) * 2024-12-13 2025-03-21 北京华睿鼎信科技有限公司 甾类化合物及其制备方法、药物组合物及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511574A (en) * 1981-01-08 1985-04-16 Mitsui Toatsu Kagaku Kabushiki Kaisha N-(4-Phenyl-2-thiazolyl)carbamate derivatives
US4699928A (en) * 1984-07-13 1987-10-13 Merrell Dow Pharmaceuticals Inc. Fluoroallylamine derivatives
IT1181871B (it) * 1985-04-01 1987-09-30 Consiglio Nazionale Ricerche Inibitori selettivi delle benzilamminossidasi rispetto ad altre amminossidasi
US4650907A (en) * 1985-12-05 1987-03-17 Merrell Dow Pharmaceuticals Inc. Nonaromatic fluoroallylamine MAO inhibitors
US4916151A (en) * 1985-12-05 1990-04-10 Merrell Dow Pharmaceuticals Inc. Method of treating parkinson's syndrome
US4965288A (en) * 1988-02-25 1990-10-23 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5021456A (en) * 1988-02-25 1991-06-04 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US4943593A (en) * 1988-02-25 1990-07-24 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5059814A (en) * 1988-11-30 1991-10-22 The California Institute Of Technology Winner-take-all circuits for neural computing systems
JPH0848664A (ja) * 1994-08-05 1996-02-20 Hisamitsu Pharmaceut Co Inc 新規なグアニジノ安息香酸エステル誘導体
GB9506188D0 (en) * 1995-03-27 1995-05-17 Fujisawa Pharmaceutical Co Amidine derivatives
CN1450997A (zh) * 2000-07-05 2003-10-22 拜奥泰治疗公司 含铜的胺氧化酶的抑制剂
AU2002214505A1 (en) * 2000-11-09 2002-05-21 Biovitrum Ab New use of 4, 5, 6, 7-tetrahydroimidazo-(4,5-c)pyridine derivatives
TWI336696B (en) * 2003-01-27 2011-02-01 Astellas Pharma Inc Thiazole derivatives
KR20120045062A (ko) * 2003-03-31 2012-05-08 가부시키가이샤 아루떼꾸 우에노 혈관 과투과 질환의 치료방법
CN1933833B (zh) * 2004-03-18 2011-09-07 株式会社·R-技术上野 含有噻唑衍生物的含水组合物

Similar Documents

Publication Publication Date Title
JP4978464B2 (ja) Vap−1阻害剤活性を有するチアゾール誘導体
JP4650412B2 (ja) チアゾール誘導体およびvap−1阻害剤としてのその使用
AU2009209885B2 (en) Thiazole derivative and use thereof as VAP-1 inhibitor
JP4758337B2 (ja) 血管透過性亢進疾患を治療する方法
US20080015202A1 (en) Thiazole Derivatives Having Vap-1 Inhibitory Activity
JP2008512346A5 (enExample)
CN1209352C (zh) 肼衍生物
US20110269953A1 (en) Nitrogen and Sulfur-Containing Heterocycle Derivatives